{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T16:36:36Z","timestamp":1795278996830,"version":"4.10.3"},"reference-count":26,"publisher":"American Association for Cancer Research (AACR)","issue":"11","funder":[{"name":"Kicks For A Cure","award":["LB-595"],"award-info":[{"award-number":["LB-595"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Familial atypical multiple mole melanoma (FAMMM) syndrome is a hereditary cancer syndrome that results from mutations in several genes, including the CDKN2A gene. In addition to melanoma, certain other malignancies such as pancreatic cancer are known to occur more frequently in family members who carry the mutation. However, as these families have been followed over time, additional cancers have been observed in both carriers and noncarriers. We sought to determine whether these additional cancers occur at higher frequencies in carriers than noncarriers. We performed survival analyses using 10 FAMMM syndrome families (N = 1,085 individuals) as well as a mixed effects Cox regression, with age at last visit to the clinic or age at cancer diagnosis as our time variable. This analysis was done separately for the known FAMMM-related cancers and \u201cother\u201d cancer groups. The survival curves showed a significant age effect with carriers having a younger age at cancer onset than noncarriers for FAMMM-related cancers (as expected) as well as for newly associated cancers. The Cox regression reflected what was seen in the survival curves, with all models being highly significant (P = 7.15E\u221220 and P = 5.00E\u221213 for the FAMMM-related and other cancers, respectively). These analyses support the hypothesis that CDKN2A mutation carriers in FAMMM syndrome families have increased risk for early onset of several cancer types beyond the known cancers. Therefore, these individuals should be screened for additional cancers, and mutation screening should be extended to more than first-degree relatives of an index carrier patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study shows that carriers of mutations in the CDKN2A gene in FAMMM syndrome are at increased risk for early onset of several cancer types beyond the known cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-18-1580","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T15:02:12Z","timestamp":1554822132000},"page":"2992-3000","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Analysis of the\n                    <i>CDKN2A<\/i>\n                    Gene in FAMMM Syndrome Families Reveals Early Age of Onset for Additional Syndromic Cancers"],"prefix":"10.1158","volume":"79","author":[{"given":"Candace D.","family":"Middlebrooks","sequence":"first","affiliation":[{"name":"1Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Stacey","sequence":"additional","affiliation":[{"name":"2Hereditary Cancer Center, Creighton University, Omaha, Nebraska."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"1Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Snyder","sequence":"additional","affiliation":[{"name":"2Hereditary Cancer Center, Creighton University, Omaha, Nebraska."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudy G.","family":"Shaw","sequence":"additional","affiliation":[{"name":"2Hereditary Cancer Center, Creighton University, Omaha, Nebraska."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami","family":"Richardson-Nelson","sequence":"additional","affiliation":[{"name":"2Hereditary Cancer Center, Creighton University, Omaha, Nebraska."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Rendell","sequence":"additional","affiliation":[{"name":"3The Rose Salter Medical Research Foundation, Newport Coast, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Ferguson","sequence":"additional","affiliation":[{"name":"2Hereditary Cancer Center, Creighton University, Omaha, Nebraska."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Silberstein","sequence":"additional","affiliation":[{"name":"4Department of Hematology\/Oncology, Creighton University, Omaha, Omaha, Nebraska."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray J.","family":"Casey","sequence":"additional","affiliation":[{"name":"2Hereditary Cancer Center, Creighton University, Omaha, Nebraska."},{"name":"5Department of Obstetrics and Gynecology, Creighton University, Omaha, Omaha, Nebraska."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-2920","authenticated-orcid":false,"given":"Joan E.","family":"Bailey-Wilson","sequence":"additional","affiliation":[{"name":"1Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry T.","family":"Lynch","sequence":"additional","affiliation":[{"name":"2Hereditary Cancer Center, Creighton University, Omaha, Nebraska."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"2022061706342830300_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2022061706342830300_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/978-1-4419-6448-9_13","article-title":"Familial cutaneous melanoma","volume":"685","author":"Hansson","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"2022061706342830300_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2022061706342830300_bib4","first-page":"562","article-title":"Case of fungoid disease","volume":"1829","author":"Norris","year":"1820","journal-title":"Edinburgh Med Surg J"},{"key":"2022061706342830300_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.1981.225","article-title":"Tumour spectrum in the FAMMM syndrome","volume":"44","author":"Lynch","year":"1981","journal-title":"Br J Cancer"},{"key":"2022061706342830300_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/jmg.20.5.342","article-title":"Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis","volume":"20","author":"Lynch","year":"1983","journal-title":"J Med Genet"},{"key":"2022061706342830300_bib7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0190-9622(87)70103-0","article-title":"Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma","volume":"16","author":"Greene","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"2022061706342830300_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006676-199103000-00001","article-title":"Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome","volume":"6","author":"Lynch","year":"1991","journal-title":"Pancreas"},{"key":"2022061706342830300_bib9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1126\/science.1439824","article-title":"Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22","volume":"258","author":"Cannon-Albright","year":"1992","journal-title":"Science"},{"key":"2022061706342830300_bib10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"2022061706342830300_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","article-title":"Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus","volume":"8","author":"Kamb","year":"1994","journal-title":"Nature genetics"},{"key":"2022061706342830300_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","article-title":"Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers","volume":"368","author":"Nobori","year":"1994","journal-title":"Nature"},{"key":"2022061706342830300_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","article-title":"Melanoma genetics","volume":"53","author":"Read","year":"2016","journal-title":"J Med Genet"},{"key":"2022061706342830300_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamadermatol.2015.4356","article-title":"Prevalence of MITF p.E318K in patients with melanoma independent of the presence of CDKN2A causative mutations","volume":"152","author":"Potrony","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2022061706342830300_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejcb.2013.10.002","article-title":"A germline oncogenic MITF mutation and tumor susceptibility","volume":"93","author":"Paillerets","year":"2014","journal-title":"Eur J Cell Biol"},{"key":"2022061706342830300_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jnci\/93.4.323","article-title":"Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families","volume":"93","author":"Plna","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2022061706342830300_bib17","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jaad.2014.06.036","article-title":"Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling","volume":"71","author":"Potrony","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2022061706342830300_bib18","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1158\/1078-0432.CCR-08-0403","article-title":"Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families","volume":"14","author":"de Snoo","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2022061706342830300_bib19","doi-asserted-by":"crossref","first-page":"42601","DOI":"10.1038\/srep42601","article-title":"Risk of other cancers in families with melanoma: novel familial links","volume":"7","author":"Frank","year":"2017","journal-title":"Sci Rep"},{"key":"2022061706342830300_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10689-016-9907-3","article-title":"Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families","volume":"15","author":"Read","year":"2016","journal-title":"Fam Cancer"},{"key":"2022061706342830300_bib21","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jnci\/djs221","article-title":"Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers","volume":"104","author":"Mukherjee","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"2022061706342830300_bib22","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1038\/sj.onc.1206736","article-title":"Germline splicing mutations of CDKN2A predispose to melanoma","volume":"22","author":"Loo","year":"2003","journal-title":"Oncogene"},{"key":"2022061706342830300_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cncr.10159","article-title":"Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome","volume":"94","author":"Lynch","year":"2002","journal-title":"Cancer"},{"key":"2022061706342830300_bib24","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1186\/1471-2156-6-S1-S127","article-title":"Mixed-effects Cox models of alcohol dependence in extended families","volume":"6","author":"Zhao","year":"2005","journal-title":"BMC Genet"},{"key":"2022061706342830300_bib25","first-page":"403","article-title":"Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits","volume":"76","author":"Holman","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"2022061706342830300_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajhg.2018.04.013","article-title":"Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes","volume":"103","author":"Whitworth","year":"2018","journal-title":"Am J Hum Genet"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/79\/11\/2992\/2777262\/2992.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/79\/11\/2992\/2777262\/2992.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T15:46:56Z","timestamp":1655480816000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/79\/11\/2992\/633165\/Analysis-of-the-CDKN2A-Gene-in-FAMMM-Syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,6,3]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-18-1580","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6510896","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6510896.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22421330.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22421330","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}